$CPSH Balance Sheet | Understand Stock

$CPSH

$3.63 +$0.13 (3.71%) Close

$CPSH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 27, 2026	Q1 FY2026 As of Mar 28, 2026	Q4 FY2025 As of Dec 27, 2025	Q3 FY2025 As of Sep 27, 2025	Q2 FY2025 As of Jun 28, 2025	Q1 FY2025 As of Mar 29, 2025	Q4 FY2024 As of Dec 28, 2024	Q3 FY2024 As of Sep 28, 2024	Q2 FY2024 As of Jun 29, 2024	Q1 FY2024 As of Mar 30, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jul 2, 2023	Q1 FY2023 As of Apr 1, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Oct 1, 2022	Q2 FY2022 As of Jul 2, 2022	Q1 FY2022 As of Apr 2, 2022	Q4 FY2021 As of Dec 25, 2021	Q3 FY2021 As of Sep 25, 2021
Current assets:
Cash and cash equivalents
Marketable securities, at fair value
Accounts receivable
Trade Accounts Receivable
Other Receivables
Total accounts receivable
Accounts receivable-other
Inventories, net
Prepaid expenses and other current assets
Total current assets
Property and equipment:
Production equipment
Furniture and office equipment
Leasehold improvements
Total cost
Accumulated depreciation and amortization
Construction in progress
Net property and equipment
Net intangible assets
Right-of-use lease asset
Deferred taxes, net
Total Assets
Current liabilities:
Borrowings against line of credit
Note payable, current portion
Accounts payable
Trade Accounts Receivable
Total accounts payable
Accrued expenses
Deferred revenue
Lease liability, current portion
Total current liabilities
Notes payable less current portion
Deferred revenue – long term
Long term lease liability
Total liabilities

Stockholders’ equity:
Common stock, $0.01 par value, authorized 20,000,000 shares; issued 14,348,786 and 13,746,242, respectively; outstanding 14,348,451 and 13,313,790, respectively; at September 25, 2021 and December 26, 2020;
Common stock, $0.01 par value, authorized 25,000,000 shares; issued 19,605,017 and 18,132,767 shares; outstanding 18,132,767 and 17,988,634 shares at each June 27, 2026 and December 27, 2025
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Less cost of 135,527 common shares repurchased at September 28, 2024 and 82,272 common shares repurchased at December 30, 2023
Less cost of 217,075 and 144,133 common shares repurchased at each June 27, 2026 and December 27, 2025
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments